Article
Genetically engineered mouse models for hereditary cancer syndromes.
Cancer science - 1 May 2023
Biswas Kajal, Mohammed Altaf, Sharan Shyam K, Shoemaker Robert H
Abstract excerpt
Advances in molecular diagnostics have led to improved diagnosis and molecular understanding of hereditary cancers in the clinic. Improving the management, treatment, and potential prevention of cancers in carriers of predisposing mutations requires preclinical experimental models that reflect the key pathogenic features of the specific syndrome associated with the mutations. Numerous genetically engineered mouse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
